KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $168.2 million.

  • Twist Bioscience's Total Non-Current Liabilities rose 19.07% to $168.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.2 million, marking a year-over-year increase of 19.07%. This contributed to the annual value of $168.2 million for FY2025, which is 19.07% up from last year.
  • Per Twist Bioscience's latest filing, its Total Non-Current Liabilities stood at $168.2 million for Q3 2025, which was up 2.09% from $164.7 million recorded in Q2 2025.
  • Over the past 5 years, Twist Bioscience's Total Non-Current Liabilities peaked at $171.9 million during Q3 2022, and registered a low of -$22.4 million during Q4 2021.
  • For the 3-year period, Twist Bioscience's Total Non-Current Liabilities averaged around $151.6 million, with its median value being $152.2 million (2024).
  • Per our database at Business Quant, Twist Bioscience's Total Non-Current Liabilities slumped by 136.43% in 2021 and then skyrocketed by 831.33% in 2022.
  • Over the past 5 years, Twist Bioscience's Total Non-Current Liabilities (Quarterly) stood at -$22.4 million in 2021, then skyrocketed by 831.33% to $163.6 million in 2022, then decreased by 13.01% to $142.3 million in 2023, then grew by 6.98% to $152.2 million in 2024, then rose by 19.07% to $168.2 million in 2025.
  • Its last three reported values are $168.2 million in Q3 2025, $164.7 million for Q2 2025, and $155.1 million during Q1 2025.